Veterinary dermatology is also referred as pet skin care, it is diagnosis, treatment, and prevention of skin problems in animals. Dermatological disorders or skin disorders are the most common medical conditions that are seen in the animals. The most common sign of a dermatological problem in animals are licking, biting, repeatedly shaking the head, and excessive scratching or chewing of fur and skin. Additional symptoms of skin problems include lumps, hair loss, dandruff, a foul odor coming from the ears or skin and a change in the texture or color pet's fur or skin.Itching is commonly seen in companion animals, for example Atopic dermatitis is the common cause of itching. For example, according to research findings conducted by Ferdowsi University of Mashhad Veterinary Teaching Hospital in Iran in 2013-2014, 20% to 40% of small animals suffer from skin problems in Iran. Globally, this number may be even higher. Alternatively, variations in clinical presentations such as the extent of lesions, genetic factors, secondary infections, stage of the disease, and weather conditions could complicate the exact diagnosis of the disease. Atopy is genetically determined predisposition to become allergic to airborne pollens such as grass, weeds, trees, mold, and house dust. In domestic pets such as cats and dogs, atopic dermatitis is the most common cause of biting, chewing, rubbing or ear infections as well as other chronic infections.
The global veterinary dermatology drugs market is projected to grow at a rapid pace in the next few years. Key factors contributing to veterinary dermatology drugs market growth are rise in demand of local anesthetics, anti-inflammatory agents, emollients to treat acne, cleansers, and anti-infectives. Moreover, increase in demand for veterinary and related products such as dairy and agriculture products and rise in awareness about veterinary dermatology drugs are anticipated to drive the global veterinary dermatology drugs market. Furthermore, advancement in techniques for the development of innovative products, rise in number of mergers, collaborations, and acquisitions between companies, vendors, and academic & research institutes are expected to drive the global veterinary dermatology drugs market. However, high cost of drugs, lack of awareness about new drugs & techniques in developing countries, and stringent rules and regulations by the governing organizations are likely to hamper the growth of the global veterinary dermatology drugs market.
The global veterinary dermatology drugs market can be segmented based on type of product, animal type, and end-user. Based on type of product, the veterinary dermatology drugs market can be classified into non-steroidal anti-inflammatory drugs (NSAIDS), antibiotics, veterinary antifungal drugs, and others. Different types of antibiotics are used to treat animal dermatology conditions; however, beta lactam antibiotics such as cephalexin or potentiated amoxicillin are most commonly used. Based on animal type, the global veterinary dermatology drugs market can be bifurcated into large animals and small animals. The small animals segment is projected to account for large market share during forecast period. In terms of end-user, the veterinary dermatology drugs market can be divided into veterinary hospitals, veterinary clinics, and others.
Based on region, the global veterinary dermatology drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period. This is attributed to rise in pet ownership, easy adoption of new products and techniques, better reimbursement policies, and advanced veterinary health care infrastructure. Europe and Asia Pacific are expected to be lucrative markets for veterinary dermatology drugs because of high demand for veterinary and related products in countries such as France, China, Germany, the U.K., Japan, and India. Moreover, increase in per capita income has led to high pet adoption rate in these countries.
Key players in the global veterinary dermatology drugs market are Merial, Zoetis, Inc., Ceva Sante Animale, Vetmedica, IDEXX Laboratories, Vetoquinol S.A., Virbac S.A., Bayer Animal Health, Boehringer Ingelheim, and Elanco.
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates are included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.